Related references
Note: Only part of the references are listed.Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study
Rainer Ganschow et al.
PEDIATRIC TRANSPLANTATION (2017)
Use of everolimus in liver transplantation
Mei-Ling Yee et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
Strategies for the management of adverse events associated with mTOR inhibitors
Bruce Kaplan et al.
TRANSPLANTATION REVIEWS (2014)
De novo therapy with everolimus and reduced-exposure cyclosporine following pediatric kidney transplantation: A prospective, multicenter, 12-month study
Carl Grushkin et al.
PEDIATRIC TRANSPLANTATION (2013)
Cancer in the Transplant Recipient
Jeremy R. Chapman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies
Zeina Al-Mansour et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2013)
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
P. De Simone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Conversion to sirolimus in pediatric renal transplant patients: A single-center experience
Marta L. Monteverde et al.
PEDIATRIC TRANSPLANTATION (2012)
Chronic Calcineurin Inhibitor Nephrotoxicity-Lest We Forget
J. R. Chapman
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients
Melanie Vallin et al.
CLINICAL TRANSPLANTATION (2011)
Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients
Maria-Sole Basso et al.
PEDIATRIC TRANSPLANTATION (2011)
The use of everolimus in pediatric liver transplant recipients: First experience in a single center
Dirk Nielsen et al.
PEDIATRIC TRANSPLANTATION (2011)
Pediatric Kidney Transplantation Followed by De Novo Therapy With Everolimus, Low-Dose Cyclosporine A, and Steroid Elimination: 3-Year Data
Lars Pape et al.
TRANSPLANTATION (2011)
De novo Therapy with Everolimus, Low-Dose Ciclosporine A, Basiliximab and Steroid Elimination in Pediatric Kidney Transplantation
L. Pape et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Calcineurin Inhibitor-Related Cholestasis Complicating Lung Transplantation
Takahiro Oto et al.
ANNALS OF THORACIC SURGERY (2010)
Management of renal dysfunction in the liver transplant recipient
Phuong-Thu T. Pham et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2009)
Sirolimus in Pediatric Liver Transplantation: A Single-Center Experience
N. E. M. Gibelli et al.
TRANSPLANTATION PROCEEDINGS (2009)
Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness
Laurence Chan et al.
TRANSPLANTATION (2008)
Late graft loss or death in pediatric liver transplantation: An analysis of the SPLIT database
K. A. Soltys et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation
Kathleen M. Campbell et al.
JOURNAL OF PEDIATRICS (2006)
Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection
R Ganschow et al.
PEDIATRIC TRANSPLANTATION (2006)
Lymphomas after solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Short- and long-term results of liver transplantation in infants aged less than 6 months
E Grabhorn et al.
TRANSPLANTATION (2004)
Chronic renal failure after transplantation of a nonrenal organ
AO Ojo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses
M Majewski et al.
TRANSPLANTATION (2003)
Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation
O Boillot et al.
CLINICAL TRANSPLANTATION (2001)
Share Paper
